Stock Events

CRISPR Therapeutics (CRSP) Q4 2023 Earnings

21FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-2.36
-1.21
-0.05
1.1

Details

Expected EPS
0.066313
Actual EPS
1.1
Surprise EPS
1.03
Surprise Percent
+1,558.8%

Description

CRISPR Therapeutics (CRSP) has reported earnings of 1.1 per share for Q4 2023.

0 Comments

Share your thoughts